Trendline Group

1 stories about Trendline Group
 Vessi Medical CEO Eyal Kochavi (right) and cryogenics expert Moti Simchon

Vessi Medical completes $1.7 million in funding for minimally invasive bladder cancer treatment

01.09.20|CTech
The company aims to conduct the first human trials of its cold therapy treatment at the beginning of 2021
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1